Company · founded 1994
Sekisui XenoTech (United States)
Lenexa, United States · xenotech.com
Part of BioIVT (United States)
- Citations, last 5 years
- 103
- Works, last 5 years
- 12
- h-index
- 58
- Scientists listed
- 1
- Grants since 2016
- 6
Grants received
2015–2020 · contract · N01
IGF::OT::IGF PURPOSE: TO FULLY FUND THE PERFORMANCE UNDER TASK ORDER 2 PERIOD OF PERFORMANCE: 09/03/2015 - 09/02/2016
David Buckley · Sekisui XenoTech (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
IGF::OT::IGF : IN VITRO METABOLISM & METABOLITE QUANTIFICATION. PERIOD OF PERFORMANCE: 07/06/2015-07/05/2020. N01DA-15-8919.
David Buckley · Sekisui XenoTech (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
IGF::OT::IGF PURPOSE: TO FULLY FUND THE PERFORMANCE UNDER TASK ORDER 2 PERIOD OF PERFORMANCE: 09/03/2015 - 09/02/2016
David Buckley · Sekisui XenoTech (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
IGF::OT::IGF PURPOSE: TO FULLY FUND THE PERFORMANCE UNDER TASK ORDER 2 PERIOD OF PERFORMANCE: 09/03/2015 - 09/02/2016
David Buckley · Sekisui XenoTech (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
TO FULLY FUND PERFORMANCE UNDER TASK ORDER NO. 9. PERIOD OF PERFORMANCE: 07/02/2020 - 09/02/2020. N01DA-15-8919.
Mark Watkins · Sekisui XenoTech (United States) · funded by National Institutes of Health
2015–2020 · contract · N01
IGF::OT::IGF : IN VITRO METABOLISM & METABOLITE QUANTIFICATION. PERIOD OF PERFORMANCE: 07/06/2015-07/05/2020. N01DA-15-8919.
David Buckley · Sekisui XenoTech (United States) · funded by National Institutes of Health